Clinical Safety and Efficacy of Dual Wavelength Low-Level Light Therapy in Androgenetic Alopecia: A Double-Blind Randomized Controlled Study

December 2024 in “ Dermatologic Surgery ”

Meryl Thomas, Max A. Stockslager, John R. Oakley, Thomas Matthew Womble, Rodney Sinclair

dual wavelength low-level light therapy LED caps androgenetic alopecia hair density AGA LED light therapy

TLDR Dual wavelength LED caps can safely increase hair density in androgenetic alopecia.

The study investigated the clinical safety and efficacy of dual wavelength low-level light therapy using LED caps for treating androgenetic alopecia (AGA) in a 26-week, multicenter, double-blind, randomized controlled trial involving 160 subjects. Although individual study arms did not show statistically significant results, the pooled analysis of the three active study arms demonstrated a significant increase in hair density, with 28.5 more hairs per cm² compared to the sham group (p = .033). The LED caps were well tolerated, indicating their potential as a treatment for AGA.

View this study on journals.lww.com →

Discuss this study in the Community →

Research cited in this study

11 / 11 results

research Photobiomodulation and Alopecia: A Crowdsourced Survey Study on Patient Preferences

November 2023 in “Journal of Cosmetic and Laser Therapy”

Most alopecia patients are open to trying light therapy, especially at-home devices, but cost is a big factor in their willingness.

research A Systematic Review and Meta-Analysis of Randomized Controlled Trials of United States Food and Drug Administration-Approved, Home-Use, Low-Level Light/Laser Therapy Devices for Pattern Hair Loss: Device Design and Technology

9 citations, November 2021 in “PubMed”

FDA-approved low-level light/laser therapy devices can significantly increase hair density in people with pattern hair loss.

research Comparison of Low-Level Light Therapy and Combination Therapy of 5% Minoxidil in the Treatment of Female Pattern Hair Loss

5 citations, October 2020 in “Lasers in Medical Science”

Combination therapy works best for female hair loss, increasing density and thickness.

Low-Level Light and Minoxidil 5% Combination Versus Either Modality Alone in Management of Female Patterned Hair Loss: A Randomized Controlled Study

research Low-Level Light and Minoxidil 5% Combination Versus Either Modality Alone in Management of Female Patterned Hair Loss: A Randomized Controlled Study

34 citations, May 2017 in “Lasers in Surgery and Medicine”

Combining low-level light therapy and minoxidil 5% is more effective for female hair loss than using either treatment alone.

research Understanding Patient and Physician Perceptions of Male Androgenetic Alopecia Treatments in Asia-Pacific and Latin America

5 citations, March 2017 in “Journal of Dermatology”

Patients and doctors find current hair loss treatments unsatisfying and believe involving patients in decisions improves results.

research Androgenetic Alopecia: New Insights Into the Pathogenesis and Mechanism of Hair Loss

33 citations, August 2015 in “F1000Research”

New model shows muscle affects hair loss differently in men and women.

research Destruction of the Arrector Pili Muscle and Fat Infiltration in Androgenic Alopecia

35 citations, March 2014 in “British Journal of Dermatology”

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

Efficacy and Safety of a Low-Level Laser Device in the Treatment of Male and Female Pattern Hair Loss: A Multicenter, Randomized, Sham Device-Controlled, Double-Blind Study

research Efficacy and Safety of a Low-Level Laser Device in the Treatment of Male and Female Pattern Hair Loss: A Multicenter, Randomized, Sham Device-Controlled, Double-Blind Study

147 citations, January 2014 in “American Journal of Clinical Dermatology”

Laser device increases hair density, safe for treating hair loss in men and women.

research Prevalence of Male and Female Pattern Hair Loss in Maryborough

193 citations, August 2005 in “Journal of Investigative Dermatology Symposium Proceedings”

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

research Hair Regrowth and Increased Hair Tensile Strength Using the HairMax LaserComb for Low-Level Laser Therapy

75 citations, August 2003 in “International journal of cosmetic surgery and aesthetic dermatology”

The HairMax LaserComb made hair grow more and get stronger for people with hair loss.

research Fortnightly Review: Male Pattern Androgenetic Alopecia

179 citations, September 1998 in “BMJ”

Hair loss in men is common, treatable, but not curable.

Similar Research

5 / 1000+ results

research The Nuts and Bolts of Low-Level Laser Therapy

1057 citations, November 2011 in “Annals of Biomedical Engineering”

Low-level Laser Therapy may help reduce inflammation, pain, and aid healing, but more research is needed to confirm its effectiveness and establish standard treatment guidelines.

research Treatment Options for Androgenetic Alopecia: Efficacy, Side Effects, Compliance, Financial Considerations, and Ethics

17 citations, November 2021 in “Journal of Cosmetic Dermatology”

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

research Microneedle Arrays Combined With Nanomedicine Approaches for Transdermal Delivery of Therapeutics

42 citations, January 2021 in “Journal of Clinical Medicine”

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

research Low-Level Laser Therapy for the Treatment of Androgenic Alopecia: A Review

41 citations, December 2017 in “Lasers in Medical Science”

Low-Level Laser Therapy (LLLT) is a safe and effective treatment for common hair loss, but more research is needed to find the best power and wavelength for treatment.

Human Type 3 5α-Reductase Is Expressed in Peripheral Tissues at Higher Levels Than Types 1 and 2 and Its Activity Is Potently Inhibited by Finasteride and Dutasteride

research Human Type 3 5α-Reductase Is Expressed in Peripheral Tissues at Higher Levels Than Types 1 and 2 and Its Activity Is Potently Inhibited by Finasteride and Dutasteride

45 citations, August 2010 in “Hormone Molecular Biology and Clinical Investigation”

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.